Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Valero Energy $650 million senior notes offering
The investment-grade notes are due 2030
GH Research $150 million follow-on offering
We advised GH Research on the offering of shares
MultiPlan $4.5 billion debt exchange
We advised an ad hoc group of convertible note holders in connection with the transaction
Strategy $584 million convertible preferred stock offering
The proceeds will be used to fund in part the acquisition of additional bitcoin
Genius Sports $150 million follow-on offering
The shares are listed on the NYSE
GeoPark $550 million notes offering and concurrent cash tender offer
We advised GeoPark on its high-yield notes offering and concurrent tender offer
Toronto-Dominion Bank $2.5 billion notes offering
The investment-grade debt offering consists of three tranches
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Kioxia Holdings ¥120.4 billion IPO
The shares are listed on the Tokyo Stock Exchange